SCHEMBL24964435

SCHEMBL24964435

CC1(C)c2ccccc2-c2ccc(-c3ccc(N(c4ccc(-c5cccc6ccccc56)cc4)c4ccccc4-c4ccc5c(c4)oc4ccccc45)cc3)cc21

nearest known ligand 0.33

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ENPP1 P22413 2/20 0.33
ENPP3 O14638 1/20 0.33
HCRTR1 O43613 1/20 0.32
CA12 O43570 3/20 0.32
CA1 P00915 3/20 0.32
CA2 P00918 3/20 0.32
CA9 Q16790 3/20 0.32
PRKDC P78527 1/20 0.32
CHRNA1 P02708 1/20 0.32
CHRNG P07510 1/20 0.32
CHRNB1 P11230 1/20 0.32
CHRNB2 P17787 1/20 0.32
SLC6A2 P23975 1/20 0.32
CHRNB4 P30926 1/20 0.32
SLC6A4 P31645 1/20 0.32
CHRNA3 P32297 1/20 0.32
CHRNA4 P43681 1/20 0.32
SLC6A3 Q01959 1/20 0.32
CHRND Q07001 1/20 0.32
ALOX5 P09917 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23238290 0.97 CHRNA1 (0.33) ENPP1ENPP3HCRTR1CA12CA1
SCHEMBL25088852 0.96 HCRTR1 (0.31) HCRTR1PRKDC
SCHEMBL24963822 0.95 PRKDC (0.32) ENPP1ENPP3HCRTR1PRKDCCHRNA1
SCHEMBL23239063 0.94 CHRNA1 (0.32) CA12CA1CA2CA9CHRNA1
SCHEMBL23237135 0.94 CHRNA1 (0.32) HCRTR1CA12CA1CA2CA9
SCHEMBL24964295 0.94 HCRTR1 (0.32) HCRTR1PRKDCALOX5MMP12MMP13
SCHEMBL24963781 0.94 ENPP1 (0.33) ENPP1ENPP3CA12CA1CA2
SCHEMBL25088845 0.94 PRKDC (0.31) ENPP1ENPP3HCRTR1PRKDCALOX5
SCHEMBL23238426 0.92 CHRNA1 (0.34) ENPP1ENPP3HCRTR1CA12CA1
SCHEMBL25842188 0.92 HCRTR1 (0.31) HCRTR1CHRNA1CHRNGCHRNB1CHRNB2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230026162-A1 COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENT, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE IDEMITSU KOSAN CO.,LTD. (JP) 2023-01-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230026162-A1 COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENT, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE L1CAM, LEF1, MLX ENPP1 1182/4885ENPP3 1970/4885HCRTR1 3134/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.